IP40 closed Friday lower at 2.08, a decrease of -0.4785% from Thursday's close, completing a monthly decrease of -0.9524% or -0.02. Over the past 12 months, IP40 stock lost -49.7585%.
IP40 is not paying dividends to its shareholders.
The last earnings report, released on Mar 31, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
InnoCan Pharma Corporation has completed 1 stock splits, with the recent split occurring on Sep 05, 2025.
The company's stock is traded on 3 different exchanges and in various currencies, with the primary listing on XDUS (EUR).